Beurs gesloten -
Swiss Exchange
17:36:57 07-09-2023
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
80
CHF
|
+33,33%
|
|
-.--%
|
-.--%
|
Fiscaal tijdperk: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
909.347
|
986.612
|
1.674.992
|
2.118.803
|
3.112.331
|
4.406.245
|
-
|
-
|
Bedrijfswaarde
1 |
898.355
|
984.211
|
1.684.152
|
2.121.013
|
3.109.107
|
4.428.780
|
4.400.670
|
4.346.327
|
K/w-verhouding
|
23,6
x
|
23,7
x
|
35,4
x
|
38,4
x
|
37,5
x
|
42,9
x
|
34,7
x
|
29
x
|
Dividendrendement
|
2,16%
|
2,13%
|
1,41%
|
1,32%
|
1,35%
|
1,19%
|
1,46%
|
1,71%
|
Marktkapitalisatie/omzet
|
7,45
x
|
7,77
x
|
11,9
x
|
12
x
|
13,4
x
|
15,1
x
|
12,5
x
|
10,8
x
|
Bedrijfswaarde/omzet
|
7,36
x
|
7,75
x
|
12
x
|
12
x
|
13,4
x
|
15,2
x
|
12,5
x
|
10,7
x
|
Bedrijfswaarde/EBITDA
|
15,5
x
|
16,4
x
|
26
x
|
25,8
x
|
27,8
x
|
31,1
x
|
24,8
x
|
20,8
x
|
Bedrijfswaarde/FCF
|
26,1
x
|
34,5
x
|
57,4
x
|
37
x
|
45,5
x
|
65,9
x
|
45,2
x
|
36,6
x
|
FCF Yield
|
3,83%
|
2,9%
|
1,74%
|
2,7%
|
2,2%
|
1,52%
|
2,21%
|
2,73%
|
Price to Book
|
15,8
x
|
15,8
x
|
24
x
|
25,6
x
|
29,4
x
|
30,4
x
|
24,3
x
|
18,9
x
|
Aantal aandelen (in duizenden)
|
4.703.720
|
4.624.923
|
4.557.801
|
4.517.704
|
4.458.288
|
4.435.073
|
-
|
-
|
Referentieprijs
2 |
193,3
|
213,3
|
367,5
|
469,0
|
698,1
|
993,5
|
993,5
|
993,5
|
Datum van publicatie
|
5/02/20
|
3/02/21
|
2/02/22
|
1/02/23
|
31/01/24
|
-
|
-
|
-
|
Fiscaal tijdperk: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
122.021
|
126.946
|
140.800
|
176.954
|
232.261
|
291.806
|
352.679
|
407.847
|
EBITDA
1 |
58.144
|
59.879
|
64.669
|
82.171
|
111.987
|
142.571
|
177.523
|
209.389
|
Bedrijfsresultaat (EBIT)
1 |
52.483
|
54.126
|
58.644
|
74.809
|
102.574
|
131.059
|
161.577
|
189.196
|
Operationele Marge
|
43,01%
|
42,64%
|
41,65%
|
42,28%
|
44,16%
|
44,91%
|
45,81%
|
46,39%
|
Resultaat voor belastingen (EBT)
1 |
48.553
|
53.130
|
59.080
|
69.062
|
104.674
|
130.702
|
159.344
|
187.372
|
Nettowinst (verlies)
1 |
38.951
|
42.138
|
47.757
|
55.525
|
83.683
|
104.108
|
128.071
|
149.055
|
Nettomarge
|
31,92%
|
33,19%
|
33,92%
|
31,38%
|
36,03%
|
35,68%
|
36,31%
|
36,55%
|
WPA
2 |
8,190
|
9,005
|
10,37
|
12,22
|
18,62
|
23,13
|
28,59
|
34,24
|
Free Cash Flow
1 |
34.451
|
28.565
|
29.319
|
57.362
|
68.326
|
67.157
|
97.420
|
118.704
|
FCF-marge
|
28,23%
|
22,5%
|
20,82%
|
32,42%
|
29,42%
|
23,01%
|
27,62%
|
29,11%
|
Kasstroomconversie (ebitda)
|
59,25%
|
47,7%
|
45,34%
|
69,81%
|
61,01%
|
47,1%
|
54,88%
|
56,69%
|
Kasstroomconversie (nettowinst)
|
88,45%
|
67,79%
|
61,39%
|
103,31%
|
81,65%
|
64,51%
|
76,07%
|
79,64%
|
Dividend per aandeel
2 |
4,175
|
4,550
|
5,200
|
6,200
|
9,400
|
11,81
|
14,54
|
17,00
|
Datum van publicatie
|
5/02/20
|
3/02/21
|
2/02/22
|
1/02/23
|
31/01/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Omzet
1 |
35.622
|
38.333
|
42.301
|
41.265
|
45.566
|
48.092
|
53.367
|
54.300
|
58.731
|
65.863
|
65.349
|
68.712
|
74.422
|
82.612
|
82.997
|
EBITDA
1 |
16.598
|
15.716
|
20.797
|
20.027
|
22.225
|
19.122
|
26.726
|
26.065
|
29.438
|
29.758
|
34.760
|
32.271
|
36.968
|
39.389
|
47.685
|
Bedrijfsresultaat (EBIT)
1 |
15.249
|
13.634
|
19.147
|
18.391
|
20.184
|
17.087
|
25.007
|
23.888
|
26.913
|
26.766
|
31.846
|
28.626
|
34.319
|
35.525
|
43.855
|
Operationele Marge
|
42,81%
|
35,57%
|
45,26%
|
44,57%
|
44,3%
|
35,53%
|
46,86%
|
43,99%
|
45,82%
|
40,64%
|
48,73%
|
41,66%
|
46,11%
|
43%
|
52,84%
|
Resultaat voor belastingen (EBT)
1 |
15.112
|
13.113
|
17.919
|
16.795
|
18.032
|
16.316
|
24.737
|
24.254
|
28.063
|
27.620
|
31.918
|
28.078
|
33.998
|
34.449
|
43.881
|
Nettowinst (verlies)
1 |
12.119
|
10.892
|
14.210
|
13.318
|
14.405
|
13.592
|
19.814
|
19.428
|
22.478
|
21.963
|
25.407
|
23.420
|
27.128
|
27.583
|
32.473
|
Nettomarge
|
34,02%
|
28,41%
|
33,59%
|
32,27%
|
31,61%
|
28,26%
|
37,13%
|
35,78%
|
38,27%
|
33,35%
|
38,88%
|
34,08%
|
36,45%
|
33,39%
|
39,13%
|
WPA
2 |
2,635
|
2,380
|
3,110
|
2,930
|
3,170
|
3,010
|
4,390
|
4,315
|
5,000
|
4,910
|
5,680
|
4,923
|
6,090
|
6,307
|
7,310
|
Dividend per aandeel
2 |
-
|
3,450
|
-
|
2,125
|
-
|
4,075
|
-
|
3,000
|
-
|
6,400
|
2,932
|
3,679
|
2,957
|
5,579
|
3,766
|
Datum van publicatie
|
3/11/21
|
2/02/22
|
29/04/22
|
3/08/22
|
2/11/22
|
1/02/23
|
4/05/23
|
10/08/23
|
2/11/23
|
31/01/24
|
2/05/24
|
-
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
1 |
-
|
-
|
9.160
|
2.210
|
-
|
22.535
|
-
|
-
|
Nettokaspositie
1 |
10.992
|
2.401
|
-
|
-
|
3.224
|
-
|
5.574
|
59.918
|
Hefboom (schuld/ebitda)
|
-
|
-
|
0,1416
x
|
0,0269
x
|
-
|
0,1581
x
|
-
|
-
|
Free Cash Flow
1 |
34.451
|
28.565
|
29.319
|
57.362
|
68.326
|
67.157
|
97.420
|
118.704
|
ROE (netto-inkomsten/eigen vermogen)
|
71,2%
|
69,7%
|
71,2%
|
72%
|
88,1%
|
83,2%
|
91%
|
83,5%
|
ROA (netto-inkomsten/totale activa)
|
33%
|
31,2%
|
28,1%
|
25,5%
|
30,1%
|
28,4%
|
29,9%
|
31,3%
|
Totale activa
1 |
118.191
|
135.267
|
169.715
|
217.883
|
277.872
|
367.143
|
428.242
|
475.608
|
Nettoactief per aandeel
2 |
12,20
|
13,50
|
15,30
|
18,30
|
23,80
|
32,70
|
40,80
|
52,40
|
Cashflow per aandeel
2 |
9,840
|
11,10
|
11,90
|
17,40
|
24,20
|
24,40
|
29,50
|
33,80
|
Capex
1 |
8.932
|
5.825
|
6.335
|
12.146
|
25.806
|
46.127
|
44.063
|
44.026
|
Capex/omzet
|
7,32%
|
4,59%
|
4,5%
|
6,86%
|
11,11%
|
15,81%
|
12,49%
|
10,79%
|
Datum van publicatie
|
5/02/20
|
3/02/21
|
2/02/22
|
1/02/23
|
31/01/24
|
-
|
-
|
-
|
Gemiddeld advies Accumuleren Laatste slotkoers
993,5
DKK Gemiddelde koersdoel
952,2
DKK Spread / Gemiddelde doel -4,16% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| +55,55% | 823 mld. | | -6,83% | 352 mld. | | +17,15% | 324 mld. | | +7,09% | 301 mld. | | +14,02% | 241 mld. | | +1,64% | 223 mld. | | +13,66% | 218 mld. | | +7,87% | 167 mld. | | -3,33% | 160 mld. |
Farmaceutische producten - Andere
|